Your session is about to expire
← Back to Search
Opioid Analgesic
hemodialysis for Chronic Kidney Disease (OCKD Trial)
Phase 4
Waitlist Available
Led By Oscar A Linares, MD
Research Sponsored by Emerio & Lourdes Linares Research and Education Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
To measure oxycodone's intradialytic mass transfer rate coefficient and oxycodone's removal rate using an ODE/PDE hemodialysis model. To implement a rational clinical strategy for estimating a patient's post-hemodialysis oxycodone restoration dose using results from an ODE/PDE model of hemodialysis.
Eligible Conditions
- Chronic Kidney Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Group I: hemodialysisExperimental Treatment1 Intervention
Oxycodone will be administered and subjects will undergo hemodialysis
Group II: controlExperimental Treatment1 Intervention
Oxycodone will be administered and subjects will undergo hemodialysis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oxycodone
FDA approved
Find a Location
Who is running the clinical trial?
Emerio & Lourdes Linares Research and Education CenterLead Sponsor
Oscar A Linares, MDPrincipal InvestigatorEmerio & Lourdes Linares Research and Education Center
Share this study with friends
Copy Link
Messenger